Low-Intensity Extracorporeal Shock Wave Therapy in Vasculogenic Erectile Dysfunction Refractory to PDE5 Inhibitors: A Prospective Study With 12- and 18-Month Outcomes. Arch Ital Urol Androl 2026, 98 (1). https://doi.org/10.4081/aiua.2026.14707.